Following FDA clearance earlier this year, Perfuze is putting forward new data comparing its super-bore aspiration catheter to conventional suction methods for removing stroke-causing blood clots, as well as the emerging approach of cyclic … [Read More...] about Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Main Content
Medical Tubing & Extrusion
Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Following FDA clearance earlier this year, Perfuze is putting forward new data comparing its super-bore aspiration catheter to conventional suction methods for removing stroke-causing blood clots, as well as the emerging approach of cyclic … [Read More...] about Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
Cordis earns FDA nod for Selution SLR drug-eluting balloon
Cordis earned FDA approval for its Selution SLR (sustained limus release) drug-eluting balloon (DEB) to treat coronary in-stent restenosis, the device developer announced today. “As the first and only sirolimus drug-eluting balloon approved in the … [Read More...] about Cordis earns FDA nod for Selution SLR drug-eluting balloon
XCath Robotics receives FDA breakthrough nod for Iris system
XCath Robotics has FDA Breakthrough Device Designation for its in-development Iris surgical robotic system for mechanical thrombectomy to treat acute ischemic stroke. Houston-based XCath says the designation provides increased opportunities to … [Read More...] about XCath Robotics receives FDA breakthrough nod for Iris system
Luma Vision wins expanded FDA nod for its cardiac procedure software
Luma Vision has won FDA clearance to expand the capabilities of its Verafeye cardiac ablation procedure intelligence platform. The privately held, Dublin, Ireland–based medtech plans to launch commercially in early 2027. The news comes about six … [Read More...] about Luma Vision wins expanded FDA nod for its cardiac procedure software
Edwards Lifesciences, Medtronic score CMS win over TAVR
Edwards Lifesciences (NYSE: EW) and Medtronic (NYSE: MDT) are among the medtech companies praising CMS’s decision to expand Medicare coverage for TAVR to people with asymptomatic severe aortic stenosis. The finalized national coverage decision, … [Read More...] about Edwards Lifesciences, Medtronic score CMS win over TAVR
Abbott earns FDA approval for new dual-energy ablation catheter
Abbott (NYSE: ABT) earned FDA approval for its new dual-energy catheter, TactiFlex Duo sensor-enabled ablation catheter. TactiFlex Duo joins Johnson & Johnson MedTech’s ThermoCool SmartTouch SF and Medtronic's Affera Sphere-9 catheter in the … [Read More...] about Abbott earns FDA approval for new dual-energy ablation catheter
Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
Corcym today announced that Cleveland Clinic doctors performed the first-in-human implantation of TriMemo, a semi-rigid ring designed to repair the tricuspid valve. The ring comprises three layers: a carbon film coating over the oval silicone … [Read More...] about Corcym achieves first-in-human implant of TriMemo for tricuspid valve repair
